User:Marvin O'Neal/OspA: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 51: | Line 51: | ||
<h2>OspA Vaccination</h2> | <h2>OspA Vaccination</h2> | ||
<Structure load="1fj1" size="350" frame="true" align="right" name="complex" caption="Outer surface protein A (OspA) in complex with the LA-2 Fab antibody ([[1fj1|1FJ1]])." scene="Studio:G2SecL03/Ospafab-orig/ | <Structure load="1fj1" size="350" frame="true" align="right" name="complex" caption="Outer surface protein A (OspA) in complex with the LA-2 Fab antibody ([[1fj1|1FJ1]])." scene="Studio:G2SecL03/Ospafab-orig/2"/> | ||
<p> | <p> | ||
| Line 62: | Line 62: | ||
<p> | <p> | ||
To address this problem of international protection it would be helpful to create a chimera, mixing the OspA of different species. In order to do this the epitope of OspA should be studied. <scene name='Studio:G2SecL03/Ospafab-fab/ | To address this problem of international protection it would be helpful to create a chimera, mixing the OspA of different species. In order to do this the epitope of OspA should be studied. <scene name='Studio:G2SecL03/Ospafab-fab/2' target="complex">LA-2</scene> is a murine monoclonal antibody that <scene name='Studio:G2SecL03/Ospafab-interaction/2' target="complex">binds strongly</scene> to <scene name='Studio:G2SecL03/Ospafab-ospa/2' target="complex">OspA</scene>, and how effective a vaccine is correlated with LA-2 binding. 5 | ||
<scene name='Studio:G2SecL03/Ospafab-orig/2' target="complex">Reset model</scene> | |||
</p> | </p> | ||
| Line 84: | Line 86: | ||
<h3> | <h3>List of Available Scenes for OspA</h3> | ||
<ul> | <ul> | ||
<li><scene name='Studio:G2SecL03/Ospa_3loopscartoon/3' target="OspA-manip">Reset model</scene><br><br></li> | <li><scene name='Studio:G2SecL03/Ospa_3loopscartoon/3' target="OspA-manip">Reset model</scene><br><br></li> | ||
